CV Sciences, Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
CVSIStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
| March 31,2026 | December 31,2025 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash | $309 | $278 |
| Accounts receivable, net | 391 | 402 |
| Inventory | 3,902 | 4,087 |
| Prepaid expenses and other | 393 | 366 |
| Total current assets | 4,995 | 5,133 |
| Property and equipment, net | 329 | 344 |
| Right of use assets | 282 | 347 |
| Intangibles, net | 68 | 76 |
| Goodwill | 1,001 | 1,015 |
| Other assets | 47 | 47 |
| Total assets | $6,722 | $6,962 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $1,080 | $1,044 |
| Accrued expenses | 2,647 | 2,447 |
| Current portion of operating lease liabilities | 246 | 247 |
| Convertible notes, at fair value | 1,135 | — |
| Current portion of long-term debt, net | 72 | 1,262 |
| Total current liabilities | 5,180 | 5,000 |
| Operating lease liabilities | 37 | 100 |
| Debt, net | — | 387 |
| Deferred tax liability | 7 | 7 |
| Total liabilities | 5,224 | 5,494 |
| Commitments and contingencies (Note 9) | ||
| Stockholders' equity | ||
| Preferred stock, par value $0.0001; 10,000 shares authorized; 1 share issued as of March 31, 2026 and December 31, 2025; and no shares outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, par value $0.0001; 790,000 shares authorized as of March 31, 2026 and December 31, 2025; 193,458 and 184,264 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 19 | 18 |
| Additional paid-in capital | 90,029 | 89,330 |
| Accumulated deficit | (88,582) | (87,939) |
| Accumulated other comprehensive income | 32 | 59 |
| Total stockholders' equity | 1,498 | 1,468 |
| Total liabilities and stockholders' equity | $6,722 | $6,962 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.